Bioretec’s ActivaPin™ bioresorbable implant provided excellent clinical outcome in the treatment of pediatric wrist fractures
Bioretec Ltd Press release 25 April 2022 at 3.00 p.m. EETThe published clinical study confirms the significant benefits of Bioretec’s bioresorbable ActivaPin™ implants for pediatric patients in the treatment of severely displaced distal radius and forearm fractures. The results of the retrospective multicenter study indicate that patients treated with bioresorbable ActivaPin™ had significantly lower level of complications than those treated with traditional non-biodegradable metallic Kirschner-wires (K-wires) and no second surgical intervention was required. Distal